Sugi Predict

Sugi Predict / Targets / SLC39A3

SLC39A3

Zinc transporter ZIP3 · Q9BRY0 · SLC39A3 on Sugi Atlas →

0 patent compounds predicted against SLC39A3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC39A3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies PHASE4COMPLETED
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus PHASE3COMPLETED
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala PHASE3COMPLETED
Oral N-acetylglucosamine in Crohn's Disease PHASE2NOT_YET_RECRUITING
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children PHASE1/PHASE2COMPLETED
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial PHASE2RECRUITING
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors PHASE1RECRUITING
Effect of, OAT3, on the Renal Secretion of Cefotaxime PHASE1COMPLETED
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Determination of Pre-Absorptive Dissociation of Zinc From a Zinc Amino Acid Complex in Healthy Men nanCOMPLETED
Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers nanCOMPLETED
Zinc and Diabetes in Patients With Thalassemia: a Pilot Study nanCOMPLETED
Zinc Sulfate Acceptability nanCOMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes nanCOMPLETED
Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients nanCOMPLETED
Zn Supplementation in HIV Immunological Non Responders nanRECRUITING
Efficacy of Zinc Fortified Fermented Wheat Flour nanCOMPLETED
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis nanNOT_YET_RECRUITING
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION
Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children nanCOMPLETED
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) nanCOMPLETED
Effects of EED on Zn Absorption and Retention in Children From a MNP nanCOMPLETED
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features nanUNKNOWN
An Evaluation of Zinc Status Biomarkers nanCOMPLETED
Role of the ATP7A Transporter in Ovarian Cancer nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Endocrine Dysfunction in Pediatric Wilson's Disease nanNOT_YET_RECRUITING
Copper Supplementation in Cirrhosis nanRECRUITING
Zinc and Iron Bioavailability From Biofortified Pearl Millet nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC39A3 binder may also engage these)

ProteinNameSimilarity
Q5E960 — 1.000 Q5E960 →
Q99K24 — 1.000 Q99K24 →
Q5U1X7 — 1.000 Q5U1X7 →
Q6QQT1 — 0.991 Q6QQT1 →
Q9NP94 — 0.991 Q9NP94 →
A4IIC5 — 0.988 A4IIC5 →
P59889 — 0.984 P59889 →
G3X943 — 0.982 G3X943 →
Q5FVQ0 — 0.976 Q5FVQ0 →
Q9C0K1 — 0.973 Q9C0K1 →
Q5BL29 — 0.973 Q5BL29 →
SLC39A14 Metal cation symporter ZIP14 0.972 landscape →
Q91W10 — 0.971 Q91W10 →
Q5RAB7 — 0.971 Q5RAB7 →
Q5ZIU9 — 0.971 Q5ZIU9 →
Q640S1 — 0.970 Q640S1 →
A0A0G2KQY6 — 0.970 A0A0G2KQY6 →
A0A3Q7ZPG5 — 0.970 A0A3Q7ZPG5 →
A4IGY6 — 0.969 A4IGY6 →
A5D7L5 — 0.969 A5D7L5 →
Q5RE57 — 0.969 Q5RE57 →
Q6NTL1 — 0.969 Q6NTL1 →
Q8BFU1 — 0.968 Q8BFU1 →
A0JPN2 — 0.968 A0JPN2 →
Q9NUM3 — 0.967 Q9NUM3 →
Q6QIX3 — 0.966 Q6QIX3 →
Q6NRM1 — 0.966 Q6NRM1 →
Q78IQ7 — 0.965 Q78IQ7 →
Q08E40 — 0.965 Q08E40 →
Q52KD7 — 0.964 Q52KD7 →